38,465 real projects from ISEF, the Canada-Wide Science Fair, JSHS, AJAS, the Calgary Youth Science Fair and the California Science & Engineering Fair — searchable by meaning, and filterable by fair, year, category and award.
ISEF · 2025
Translational Medical Science Fourth Award
Rheumatoid Arthritis (RA) is an autoimmune arthropathy that affects over 18 million people globally, causing immense joint pain and swelling. Current treatments (e.g., methotrexate, adalimum…
ISEF · 2025
Biomedical and Health Sciences Fourth Award
Inflammation is the body's natural response to combat infections, allergies, or injuries. The most commonly available treatments—non-steroidal anti-inflammatory drugs (NSAIDs) and corticoste…
ISEF · 2025
Translational Medical Science
Commonly known as the yellow water lily root or kaandoosh in Ojibwe language, the rhizome of Nuphar advena is utilized by Indigenous communities for treating a wide variety of ailments, incl…
ISEF · 2025
Translational Medical Science
Stroke, the fifth leading cause of death and a major cause of disability in the US, is a time-critical emergency handled by EMS agencies—20% of which manage 80% of service calls (Krohmer & E…
AJAS · 2025
Biomedical and Health Sciences (inferred)
Mammograms are currently the primary method used for breast cancer detection. Although they have become much more commonplace in the past few decades, they still remain shockingly inaccurate…
ISEF · 2025
Translational Medical Science Third Award
Diabetic macular edema (DME) is a leading cause of vision impairment, affecting up to 30% of diabetics. It results from retinal fluid buildup due to vascular leakage and is commonly treated…
ISEF · 2025
Biomedical and Health Sciences Fourth Award
Duchenne Muscular Dystrophy (DMD) is an inherited X-linked disease with an incidence of 1:3,600. Patients become weak at 2-3 years old with progression to respiratory failure and death in th…
ISEF · 2025
Biomedical and Health Sciences
Colorectal cancer (CRC) is the third most common cancer globally, with over 1.9 million new cases and nearly 1 million deaths annually. The incidence of early-onset CRC, defined as cancer oc…
ISEF · 2025
Biomedical and Health Sciences Fourth Award
Immune checkpoint inhibitors (ICIs) have emerged as a promising therapy for late-stage lung cancer. However, the response rate to ICIs remains low. As a result, there is a need to better und…
ISEF · 2025
Translational Medical Science
Metabolic disorders and malnutrition remain critical health concerns, often undiagnosed due to invasive, costly, and inaccessible testing methods. VitalEdge is a novel non-invasive biosensor…
ISEF · 2025
Translational Medical Science
Wound care management is a major medical challenge, causing significant clinical, social, and economic burden. To address this, I developed WoundView, an AI-powered app for real-time wound a…